Interleukin‑6 (IL‑6) is a multifunctional cytokine produced by immune and other cells. It triggers the acute‑phase response in the liver (raising CRP), induces fever, promotes B‑cell maturation and antibody production, influences T‑cell differentiation (including Th17), and recruits neutrophils. IL‑6 affects metabolism and tissue repair and can have both pro‑ and anti‑inflammatory effects depending on signaling context.

High interleukin‑6 (IL‑6) indicates increased systemic inflammation. It can reflect acute infection, autoimmune flares, trauma or surgery, chronic inflammatory conditions, obesity/metabolic syndrome, or malignancy; very high levels occur in cytokine‑release syndromes and severe infections. Elevated IL‑6 signals higher disease activity and cardiovascular risk and requires clinical correlation and investigation to identify and treat the underlying cause.

Interleukin‑6 is implicated in many inflammatory and immune-mediated conditions, including rheumatoid arthritis, systemic lupus erythematosus, juvenile idiopathic arthritis, Castleman disease, severe infections/sepsis and COVID‑19 cytokine storm. Elevated IL‑6 associates with atherosclerosis, metabolic syndrome and type 2 diabetes, certain cancers (multiple myeloma, breast, prostate), inflammatory bowel disease and neuroinflammatory disorders such as Alzheimer’s disease.

Interleukin‑6 (IL‑6) is both beneficial and potentially harmful. In acute infection or injury it helps coordinate immune defense, stimulates acute‑phase responses, fever, and tissue repair. However, chronically elevated IL‑6 drives persistent inflammation linked to autoimmune diseases, cardiovascular disease, insulin resistance, and cancer. Targeted therapies that block IL‑6 can reduce harmful chronic inflammation while preserving needed immune responses under medical supervision.

Foods that tend to raise IL‑6 include those high in saturated and trans fats (fried foods, fatty red meat, processed meats), refined carbohydrates and sugars (white bread, pastries, sweetened beverages), ultra‑processed foods, and alcohol. Diets very high in omega‑6 vegetable oils and chronic overconsumption leading to obesity also promote higher inflammatory IL‑6 levels.

Yes. Acute exercise markedly raises interleukin‑6 (IL‑6): contracting skeletal muscle releases IL‑6 as a myokine in proportion to exercise intensity and duration, peaking during/after activity. This transient IL‑6 can have anti‑inflammatory effects (e.g., stimulating IL‑10, suppressing TNF). Regular exercise, however, lowers chronically elevated baseline IL‑6 by reducing fat and systemic inflammation.